Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004091 · ClinicalTrials.gov registry record
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 100
- Enrollment target
NCT00004091: Completed study, sponsored by Northwestern University.
NCT00004091 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004091 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment. PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.
Interventions
- OTHER cytology specimen collection procedure
- PROCEDURE study of high risk factors
- OTHER Papanicolaou test
- OTHER fluorescent antibody technique
- PROCEDURE colposcopic biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 1999-08 |
| Est. Completion | 2001-02 |
What the finished NCT00004091 record still lists
NCT00004091 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which cytology specimen collection procedure is the first listed.
NCT00004091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004091 about?
NCT00004091 is a clinical study titled "Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results". RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment. PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.
What is the current status of trial NCT00004091?
This trial is currently completed. The enrollment target is 100 participants. The study started on 1999-08. Estimated completion is 2001-02.
What interventions are being tested in trial NCT00004091?
The interventions under investigation include: cytology specimen collection procedure (OTHER), study of high risk factors (PROCEDURE), Papanicolaou test (OTHER), fluorescent antibody technique (OTHER), colposcopic biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00004091?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia